About Afluria.com

Afluria.com is an informative resource regarding influenza for consumers and healthcare professionals. The Website is brought to you by CSL Biotherapies (a subsidiary of CSL Limited). CSL Limited has more than 90 years of experience in developing and manufacturing vaccines, with nearly 40 years’ experience in influenza vaccines. For more information about CSL Biotherapies, please visit CSLBiotherapies.com.

The Marketing, Medical Affairs, Regulatory, Legal, and IS departments of CSL Biotherapies are responsible for the content and development of Afluria.com.

The information provided on Afluria.com is designed to support, not replace, the relationship that exists between you and your physician.

Informational content shows the date content was first published and the date the content was last updated.

Afluria.com does not host or receive funding from advertising.

For more information or if you have any questions, please contact the Webmaster at Webmaster@afluria.com.

Important Safety Information

Afluria^® is indicated for active immunization of persons 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. The indication is based on the immune response elicited by Afluria^®; no controlled clinical studies have demonstrated a decrease in influenza disease after vaccination with Afluria^®.

Afluria^® should not be administered to individuals with hypersensitivity to eggs or chicken protein or other components of Afluria^®, or to anyone who has had a life-threatening reaction to previous influenza vaccination. The most common injection-site adverse reactions were tenderness, pain, redness, and swelling. The most common systemic adverse reactions were headache, malaise, and muscle aches.

Vaccination with Afluria^® may not protect all individuals. Immunocompromised persons may have a diminished immune response. If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior influenza vaccine, the decision to give Afluria^® should be based on careful consideration of the potential benefits and risks.

Click here for full PRESCRIBING INFORMATION.